An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity
Yik A. Yeung, Veena Krishnamoorthy, Danielle Dettling, Cesar Sommer, Kris Poulsen, Irene Ni, Amber Pham, Wei Chen, Sindy Liao-Chan, Kevin C. Lindquist, Sherman M. Chin, Allison G. Chunyk, Wenyue Hu, Barbra J. Sasu, Javier Chaparro‐Riggers, Ivana M. Djuretic
Topics & Concepts
Bispecific antibodyToxicityLeukemiaAntibodyCancer researchChemistryPharmacologyMedicineMolecular biologyImmunologyBiologyInternal medicineMonoclonal antibodyCAR-T cell therapy researchAcute Myeloid Leukemia ResearchAdvanced biosensing and bioanalysis techniques